Ligand Reports Second Quarter 2026 Financial Results
Ligand reported Q2 revenue of $63.7 million, up 34% year-over-year, driven by a 32% increase in royalty revenue to $48.0 million. Adjusted EPS reached $2.37, reflecting strong year-over-year growth supported by gains from its royalty portfolio and strategic investments. The company closed the XOMA Royalty acquisition, adding over 120 assets, and completed a $700 million 0% convertible debt financing. These moves significantly expand Ligand's portfolio and strengthen its capital position with $1.36 billion in cash and equivalents.
Key figures
- Eps
- 2.37
- Revenue
- $63.7 million
- Guidance
- FY26 revenue $270M-$310M; Adjusted EPS $9.00-$9.50 (raised from $8.50-$9.50)
- Revenue Yoy
- 34%
- Royalty revenue
- $48.0 million
- Cash equivalents
- $1.36 billion
- Adjusted net income
- $50.8 million
- Royalty revenue yoy
- 32%
- Convertible debt face
- $700 million
- Convertible debt proceeds
- $679 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.